1. Home
  2. MCHX vs WHWK Comparison

MCHX vs WHWK Comparison

Compare MCHX & WHWK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MCHX
  • WHWK
  • Stock Information
  • Founded
  • MCHX 2003
  • WHWK 2007
  • Country
  • MCHX United States
  • WHWK United States
  • Employees
  • MCHX N/A
  • WHWK N/A
  • Industry
  • MCHX Business Services
  • WHWK Biotechnology: Pharmaceutical Preparations
  • Sector
  • MCHX Consumer Discretionary
  • WHWK Health Care
  • Exchange
  • MCHX Nasdaq
  • WHWK Nasdaq
  • Market Cap
  • MCHX 84.3M
  • WHWK 82.4M
  • IPO Year
  • MCHX 2004
  • WHWK N/A
  • Fundamental
  • Price
  • MCHX $2.13
  • WHWK $1.78
  • Analyst Decision
  • MCHX
  • WHWK
  • Analyst Count
  • MCHX 0
  • WHWK 0
  • Target Price
  • MCHX N/A
  • WHWK N/A
  • AVG Volume (30 Days)
  • MCHX 18.4K
  • WHWK 105.5K
  • Earning Date
  • MCHX 08-12-2025
  • WHWK 08-15-2025
  • Dividend Yield
  • MCHX N/A
  • WHWK N/A
  • EPS Growth
  • MCHX N/A
  • WHWK N/A
  • EPS
  • MCHX N/A
  • WHWK 0.91
  • Revenue
  • MCHX $47,951,000.00
  • WHWK $27,775,000.00
  • Revenue This Year
  • MCHX $5.77
  • WHWK $49.83
  • Revenue Next Year
  • MCHX N/A
  • WHWK N/A
  • P/E Ratio
  • MCHX N/A
  • WHWK $1.95
  • Revenue Growth
  • MCHX N/A
  • WHWK 16.51
  • 52 Week Low
  • MCHX $1.26
  • WHWK $1.21
  • 52 Week High
  • MCHX $2.40
  • WHWK $3.81
  • Technical
  • Relative Strength Index (RSI)
  • MCHX 61.52
  • WHWK N/A
  • Support Level
  • MCHX $1.89
  • WHWK N/A
  • Resistance Level
  • MCHX $2.04
  • WHWK N/A
  • Average True Range (ATR)
  • MCHX 0.09
  • WHWK 0.00
  • MACD
  • MCHX -0.00
  • WHWK 0.00
  • Stochastic Oscillator
  • MCHX 96.00
  • WHWK 0.00

About MCHX Marchex Inc. Class B

Marchex Inc is a conversational analytics and solutions company that helps businesses connect, drive, measure, convert callers into customers, and connect the voice of the customer to their business. It delivers data insights and incorporates artificial intelligence (AI)-powered functionality that drives insights and solutions to help companies find, engage, and support their customers across voice and text-based communication channels. The group enables sales and marketing teams to deliver the buying experiences that today's customers expect. The company generates the majority of its revenues from core analytics and solutions services. The company operates in the United States, Canada, and other countries.

About WHWK Whitehawk Therapeutics Inc. Common Stock

Whitehawk Therapeutics Inc is a preclinical stage oncology therapeutics. The company is engaged in applying technologies to established tumor biology to efficiently deliver improved cancer treatments. The company's three-asset ADC portfolio is engineered to overcome the limitations of first-generation predecessors to deliver a meaningful impact for patients with difficult-to-treat cancers.

Share on Social Networks: